IL1B and peritonitis: In vivo (LPS-induced peritonitis), MCHLE reduced total leukocyte and neutrophil influx and lowered TNF-α and NO levels to values comparable to dexamethasone; in vitro (LPS-stimulated RAW 264.7), it produced dose-dependent inhibition of TNF-α, IL-1β, and NO.